{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:38:34Z","timestamp":1792093114059,"version":"4.4.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To examine the ocular surface disease in primary open-angle glaucoma (POAG) patients already on treatment versus POAG patients without treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective cohort study was conducted on 120 eyes of 60 POAG patients: 60 treatment-na\u00efve eyes (group I) and 60 eyes already on topical anti-glaucoma medications (AGMs) (group II). All patients had filled out the Ocular Surface Disease Index (OSDI) questionnaire and underwent a comprehensive glaucoma workup. Tear break-up time (TBUT) test, Schirmer\u2019s test (type I), corneal sensitivity, anterior segment-optical coherence tomography (AS-OCT), and corneal and conjunctival staining were done at day 1, 1 month, 3 months, 6 months, and 12 months follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>On presentation, TBUT, Schirmer\u2019s test, tear meniscus height (TMH), and tear meniscus depth (TMD) were significantly higher in group I compared to group II. No significant difference was noted in OSDI score, corneal sensitivity, and tear meniscus area (TMA) between the groups on presentation. Both, lissamine green and rose bengal staining, had higher grades in group II compared to group I. Worsening of ocular surface disease was noted in both groups on follow-up. OSDI score, TBUT, Schirmer\u2019s test, TMH, and TMD had better values in group I in comparison to group II on follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The study has identified glaucoma patients on AGMs to be more affected by dry eye disease (DED) compared to treatment-naive glaucoma patients. We found statistically significant differences in values of TBUT, Schirmer tests, lissamine and rose bengal staining, and AS-OCT parameters at baseline and 3, 6, and 12 months follow-up. OSDI scores showed significant differences at 6 and 12 months of follow-up. We recommend consideration of evaluation and management of DED\/ocular surface disease in glaucoma patients on topical AGMs, particularly multiple drugs and doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_618_23","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T05:00:35Z","timestamp":1702616435000},"page":"374-380","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Ocular surface changes in primary open-angle glaucoma on anti-glaucoma medications versus treatment-na\u00efve patients"],"prefix":"10.4103","volume":"72","author":[{"given":"Krati","family":"Srivastava","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita R","family":"Bhatnagar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Shakrawal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tandon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Jaisingh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, AIIMS, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"R1-20260504","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"R2-20260504","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R3-20260504","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2011.01.047","article-title":"Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study","volume":"118","author":"Musch","year":"2011","journal-title":"Ophthalmology"},{"issue":"Suppl","key":"R4-20260504","first-page":"S82","article-title":"Management of angle closure glaucoma","volume":"59","author":"See","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"R5-20260504","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R6-20260504","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1167\/iovs.15-17455","article-title":"The ocular surface in medically controlled glaucoma: An in vivo confocal study","volume":"57","author":"Villani","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20260504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5301\/ejo.5000181","article-title":"Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension","volume":"23","author":"Baudouin","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"R8-20260504","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/ICU.0b013e32835c8aba","article-title":"Glaucoma therapy and ocular surface disease: Current literature and recommendations","volume":"24","author":"Anwar","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R9-20260504","doi-asserted-by":"crossref","first-page":"696328.","DOI":"10.1155\/2013\/696328","article-title":"How ocular surface disease impacts the glaucoma treatment outcome","volume":"2013","author":"Ka\u0161telan","year":"2013","journal-title":"BioMed Res Int"},{"key":"R10-20260504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtos.2018.03.002","article-title":"Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye","volume":"16","author":"Wong","year":"2018","journal-title":"Ocul Surf"},{"key":"R11-20260504","first-page":"557","article-title":"[Ocular surface injury resulted from topical anti-glaucoma medications: Prevention and cure]","volume":"48","author":"Ouyang","year":"2012","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"R12-20260504","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: Human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"key":"R13-20260504","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/IJG.0000000000001469","article-title":"Tear meniscus imaging by anterior segment-optical coherence tomography in medically controlled glaucoma","volume":"29","author":"Agnifili","year":"2020","journal-title":"J Glaucoma"},{"key":"R14-20260504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0377-1237(07)80011-6","article-title":"Ocular surface changes in primary open angle glaucoma with long term topical anti glaucoma medication","volume":"63","author":"Kamath","year":"2007","journal-title":"Med J Armed Forces India"},{"key":"R15-20260504","first-page":"e222","article-title":"Ocular surface disease in glaucoma: Effect of polypharmacy and preservatives","volume":"92","author":"Ramli","year":"2015","journal-title":"Optom Vis Sci Off Publ Am Acad Optom"},{"key":"R16-20260504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.35119\/asjoo.v16i2.382","article-title":"Prevalence of ocular surface disease in patients with glaucoma on topical medications","volume":"16","author":"Pai","year":"2018","journal-title":"Asian J Ophthalmol"},{"key":"R17-20260504","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/OPTH.S81247","article-title":"Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma","volume":"9","author":"Cvenkel","year":"2015","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"R18-20260504","doi-asserted-by":"crossref","first-page":"694","DOI":"10.5301\/ejo.5000977","article-title":"Ocular surface disease in patients under topical treatment for glaucoma","volume":"27","author":"P\u00e9rez-Bartolom\u00e9","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"R19-20260504","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jfo.2011.07.011","article-title":"[Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension]","volume":"34","author":"Van Went","year":"2011","journal-title":"J Fr Ophtalmol"},{"key":"R20-20260504","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/JOCO.JOCO_226_20","article-title":"Risk factors for ocular surface disease in tunisian users of preserved antiglaucomatous eye drops","volume":"33","author":"Lajmi","year":"2021","journal-title":"J Curr Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_618_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:53:27Z","timestamp":1787763207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_618_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_618_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"assertion":[{"value":"2023-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}